लोड हो रहा है...
Targeting NRF2 for the Treatment of Friedreich’s Ataxia: A Comparison among Drugs
NRF2 (Nuclear factor Erythroid 2-related Factor 2) signaling is impaired in Friedreich’s Ataxia (FRDA), an autosomal recessive disease characterized by progressive nervous system damage and degeneration of nerve fibers in the spinal cord and peripheral nerves. The loss of frataxin in patients result...
में बचाया:
| में प्रकाशित: | Int J Mol Sci |
|---|---|
| मुख्य लेखकों: | , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
MDPI
2019
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6829337/ https://ncbi.nlm.nih.gov/pubmed/31640150 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20205211 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|